Study 2: Learning New Words From Overhearing in Children With Autism Spectrum Disorder (ASD)

Sponsor

New York University (Other)

Overall Status

Recruiting

CT.gov ID

NCT05192109

Collaborator

Emerson College (Other)

100

Enrollment

Locations

Arms

Anticipated Duration (Months)

Patients Per Site

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The goal of this research is to explore abilities to learn word meanings from overheard conversations in children with ASD (and, as a control, typically developing children).

Specific Aim 2 (Experiment 2): Determine whether children with ASD can learn from addressed and overheard teaching via videoconferencing. The investigators will use a similar procedure to Study 1, except that both overheard and directed teaching will take place on video.

Condition or Disease	Intervention/Treatment	Phase
Autism Spectrum Disorder	Behavioral: Overheard Speech Behavioral: Addressed Speech	N/A

Study Design

Study Type:

Interventional

Anticipated Enrollment :

100 participants

Allocation:

Non-Randomized

Intervention Model:

Parallel Assignment

Masking:

Single (Investigator)

Primary Purpose:

Basic Science

Official Title:

Study 2: Learning New Words From Overhearing in Children With Autism Spectrum Disorder (ASD)

Actual Study Start Date :

Dec 1, 2020

Anticipated Primary Completion Date :

Feb 1, 2025

Anticipated Study Completion Date :

Feb 1, 2025

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: Addressed Children participate via video in an interaction with an experimenter who uses the word to be learned.	Behavioral: Addressed Speech New words are introduced directly to the child by an experimenter.
Experimental: Overheard Children watch via video while an experimenter uses the word to be learned in an interaction with another experimenter.	Behavioral: Overheard Speech New words are introduced with the child as a bystander rather directly taught.

Arm

Intervention/Treatment

Active Comparator: Addressed

Children participate via video in an interaction with an experimenter who uses the word to be learned.

Behavioral: Addressed Speech

New words are introduced directly to the child by an experimenter.

Experimental: Overheard

Children watch via video while an experimenter uses the word to be learned in an interaction with another experimenter.

Behavioral: Overheard Speech

New words are introduced with the child as a bystander rather directly taught.

Outcome Measures

Primary Outcome Measures

Proportion of time during which children's eye gaze is directed toward the target object [immediately after intervention]
Children's eye gaze is recorded as they look at images. The proportion of time during which gaze is directed to an image of the targeted word is the dependent measure.
Proportion of time during which children's eye gaze is directed toward the target object [after 5 minutes]
Children's eye gaze is recorded as they look at images. The proportion of time during which gaze is directed to an image of the targeted word is the dependent measure.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Months to 71 Months

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

children with or without a diagnosis of ASD between 18 to 71 months of age

Exclusion Criteria:

native language is not English born premature (< 36 weeks) has uncorrected hearing or vision impairments has developmental disorders or medical conditions other than ASD that affect language or cognition (excepting psychiatric conditions often comorbid with ASD such as ADHD) has a history of photosensitive epileptic seizures

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Emerson College	Boston	Massachusetts	United States	02116
2	New York University	New York	New York	United States	10012

Sponsors and Collaborators

New York University
Emerson College

Investigators

None specified.

Study Documents (Full-Text)

Informed Consent Form - Oct 20, 2020

More Information

Publications

None provided.

Responsible Party:

New York University

ClinicalTrials.gov Identifier:

NCT05192109

Other Study ID Numbers:

280522

First Posted:

Jan 14, 2022

Last Update Posted:

Mar 31, 2022

Last Verified:

Mar 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Autistic Disorder

Autism Spectrum Disorder

Child Development Disorders, Pervasive

Study Results

No Results Posted as of Mar 31, 2022